Rapport Therapeutics (NASDAQ:RAPP – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect Rapport Therapeutics to post earnings of ($0.62) per share for the quarter.
Rapport Therapeutics Stock Down 2.5 %
Shares of Rapport Therapeutics stock opened at $12.68 on Friday. The stock has a 50 day moving average price of $16.11 and a two-hundred day moving average price of $19.85. Rapport Therapeutics has a 12-month low of $12.09 and a 12-month high of $29.74.
About Rapport Therapeutics
See Also
- Five stocks we like better than Rapport Therapeutics
- How Can Investors Benefit From After-Hours Trading
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Quiet Period Expirations Explained
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Rapport Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapport Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
